Skip to content
10-Q

Quarterly Report

BioNeutral Group, Inc

0001213900-14-001438

← back to feed
Filed
Mar 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Feb 26, 2014 1.04B sh
Operating Cash Flow Q1 2014 · Jan 31, 2014 −$198.46K
Operating Cash Flow Q1 2014 · Jan 31, 2013 −$308.04K
Cash And Equivalents Q1 2014 · Jan 31, 2014 $1.24K
Cash And Equivalents Q1 2014 · Oct 31, 2013 $702
Cash And Equivalents Q1 2014 · Jan 31, 2013 $637
Cash And Equivalents Q1 2014 · Oct 31, 2012 $676
Cash And Equivalents Q1 2014 · Jul 31, 2012 $70.49K
Cash And Equivalents Q1 2014 · Oct 31, 2011 $3.22K
Stockholders Equity Q1 2014 · Jan 31, 2014 $4.78M
Stockholders Equity Q1 2014 · Oct 31, 2013 $5.38M
Current Liabilities Q1 2014 · Jan 31, 2014 $3.01M
Current Liabilities Q1 2014 · Oct 31, 2013 $2.6M
Total Liabilities Q1 2014 · Jan 31, 2014 $4.54M
Total Liabilities Q1 2014 · Oct 31, 2013 $4.06M
Current Assets Q1 2014 · Jan 31, 2014 $21.64K
Current Assets Q1 2014 · Oct 31, 2013 $25.11K
Total Assets Q1 2014 · Jan 31, 2014 $9.1M
Total Assets Q1 2014 · Oct 31, 2013 $9.28M
Net Income Q1 2014 · Jan 31, 2014 −$751.38K
Net Income Q1 2014 · Jan 31, 2013 −$697.12K
Operating Income Q1 2014 · Jan 31, 2014 −$694.26K
Operating Income Q1 2014 · Jan 31, 2013 −$680.87K
Gross Profit Q1 2014 · Jan 31, 2014 $5.07K
Gross Profit Q1 2014 · Jan 31, 2013 $352
Cost Of Revenue Q1 2014 · Jan 31, 2014 $1.93K
Cost Of Revenue Q1 2014 · Jan 31, 2013 $203
Revenue Q1 2014 · Jan 31, 2014 $7K
Revenue Q1 2014 · Jan 31, 2013 $555